Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - MEDQUIST INC | w78320exv32w1.htm |
EX-31.1 - EX-31.1 - MEDQUIST INC | w78320exv31w1.htm |
EX-32.2 - EX-32.2 - MEDQUIST INC | w78320exv32w2.htm |
EX-31.2 - EX-31.2 - MEDQUIST INC | w78320exv31w2.htm |
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K/A
(Amendment
No. 1)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2009
Commission file number 0-19941
MEDQUIST INC.
(Exact name of registrant as specified in its charter)
New Jersey (State or other jurisdiction of incorporation or organization) |
22-2531298 (I.R.S. Employer Identification No.) |
1000 Bishops Gate Blvd, Suite 300, Mount Laurel, NJ 08054-4632
(Address of principal executive offices)
(Address of principal executive offices)
Registrants telephone number, including area code:
(856) 206-4000
(856) 206-4000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Name of each exchange on which registered | |
Common Stock, no par value per share | The NASDAQ Stock Market LLC |
Securities registered pursuant to Section 12(g) of the Act:
None
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule
405 of the Securities Act. Yes o No þ
Indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or Section 15(d) of the Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein and will not be contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. o
Indicate by check mark whether registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer or a smaller reporting company. See definition of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer o | Accelerated filer þ | Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). Yes o No þ
The aggregate market value of the outstanding common stock held by non-affiliates of the
registrant as of June 30, 2009, was $68,730,000. Such aggregate market value was computed by
reference to the closing price of the common stock as reported on the Global Market of The NASDAQ
Stock Market LLC on June 30, 2009.
The number of registrants shares of common stock, no par value, outstanding as of April 15,
2010 was 37,555,893.
Documents incorporated by reference
None
TABLE OF CONTENTS
Table of Contents
Explanatory Note
MedQuist Inc. (which may be referred to herein as we, us or the Company) is filing this
Amendment No. 1 to its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2009 to
amend and restate Items 10 through 14 to include the information intended to be incorporated
therein by reference to our definitive Proxy Statement with respect to our Annual Meeting of
Shareholders for 2010, which information was previously intended to be filed with the Securities
and Exchange Commission (SEC) within 120 days following the end of our fiscal year ended December
31, 2009. In addition, in connection with the filing of this Form 10-K/A and pursuant to Rule
12b-15 under the Securities Exchange Act of 1934 (Exchange Act), we are including certain currently
dated certifications. The remainder of the Companys Annual Report on Form 10-K for the fiscal
year ended December 31, 2009 filed with the Securities and Exchange Commission (SEC) on March 12,
2010 remains unchanged.
PART III
ITEM 10. | DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT. |
Identification of Our Directors
Our business, property and affairs are managed by, or under the direction of, our board of
directors. Each director holds office until his successor is elected and qualified, or until his
earlier resignation or removal. Set forth below is the biographical information for each of our
directors, including age, business experience for the last five years, any public company
directorships held during the last five years, memberships on committees of our board of directors
and the date when each director first became a member of our board of directors. We are not aware
of any arrangements or understandings between any of the individuals listed below and any other
person pursuant to which such individual was or is to be selected as a director, other than any
arrangements or understandings with our directors acting solely in their capacities as such.
Robert Aquilina, 54, has served as chairman of our board of directors since August 2008 and
currently serves as chairman of the Compensation Committee. Mr. Aquilina has served as an Executive
Partner, a senior operating consultant role, to S.A.C. Private Capital Group, LLC (SAC PCG) since
2007. Previously, he served as an Industrial Partner at Ripplewood Holdings LLC (Ripplewood), held
the role of Co-Chairman of Flag Telecom Group Ltd. and was a board member of Japan Telecom Inc.
Prior to these positions, Mr. Aquilina was a senior operating executive of AT&T, Inc. with a
21-year career. His last post at AT&T was as Co-President of AT&T Consumer Services and a member of
the Chairmans Operating Group. Previously within AT&T, Mr. Aquilina held a variety of senior
positions including President of Europe, Middle East & Africa, Vice Chairman of AT&T Unisource,
Vice Chairman of WorldPartners, Chairman of AT&T-UK, and General Manager of Global Data Services.
Mr. Aquilina holds an M.B.A. from The University of Chicago and a Bachelors of Engineering degree
from The Cooper Union for the Advancement of Science & Art in New York (Cooper Union). Mr. Aquilina
has been a Member of Cooper Unions Board of Trustees since 2000 and is currently chairing Cooper
Unions audit committee. Mr. Aquilina also currently serves as the chairman of the board of
directors of CBaySystems Holdings Ltd. (CBay Holdings), which is a public company listed the AIM of
the London Stock Exchange and the parent company of our majority shareholder, CBay Inc. (CBay
Inc.).
Mr. Aquilinas extensive executive and senior management experience, and prior board
service, enable him to provide leadership and support to the Company in the areas of operations,
strategic and financial planning and compensation matters, and render him well-suited to lead our
Compensation Committee.
-2-
Table of Contents
Frank Baker, 38, has served as a member of our board of directors since August 2008 and
currently serves as a member of the Compensation Committee and of the Nominating Committee. Mr.
Baker is a Managing Director and co-founder of SAC PCG. Prior to establishing SAC PCG in 2007, Mr.
Baker was a Managing Director at Ripplewood and RHJ International where he was responsible for
making various private equity investments and taking RHJ International public on the Brussels Stock
Exchange. He joined Ripplewoods New York office in 1999 and transferred to Ripplewood Japan, Inc.
in 2002. Prior to joining Ripplewood, Mr. Baker spent more than three years in investment banking
as an Associate at J.P. Morgan Securities Inc. in the Capital Markets Group and as an Analyst at
Goldman Sachs & Co. in the Mergers and Acquisitions Group. Mr. Baker has a B.A. in Economics from
the University of Chicago and an M.B.A. from Harvard Business School. Mr. Baker is also currently
on the board of directors of CBay Holdings.
Mr. Bakers vast experience in private equity capital markets, his background in mergers
and acquisitions and corporate finance matters, and his entrepreneurial and leadership skills
enable him to provide leadership and support to the Company areas of operations, financial
planning, and assessing strategic opportunities
Peter E. Berger, 60, has served as a member of our board of directors since August 2008 and
currently serves as a member of the Compensation Committee and as chairman of the Nominating
Committee. Mr. Berger is a Managing Director and co-founder of SAC PCG. From 1995-1998 and
2000-2006, Mr. Berger, a founding member of Ripplewood, served as both a Managing Director of
Ripplewood and as a Special Senior Advisor to the board of directors of RHJ International. Prior to
joining Ripplewood, Mr. Berger was a senior partner and global head of the Corporate Finance Group
at Arthur Andersen & Co., where he began his career in 1974. From 1989-1991, he served as a
Managing Director in investment banking at Bear Stearns Companies. From 1999-2000, Mr. Berger was
Managing Director and Chief Executive Officer of Mediacom Ventures LLC, a boutique investment
advisory firm. He also served as non-executive Chairman of the Board of Kepner-Tregoe, Inc., a
management consulting company. Mr. Berger has a B.Sc. from Boston University and an M.B.A. from
Columbia University Graduate School of Business. Mr. Berger is also currently on the board of
directors of CBay Holdings.
Mr. Bergers investment banking background, experience in private equity capital markets, deep
professional background and experience, and current and previously held senior-executive leadership
positions enable him to provide valuable leadership and support to the Company in the areas of
financial and strategic planning.
John F. Jastrem, 54, has served as a member of our board of directors since September 2008 and
currently serves as a member of the Audit Committee. Mr. Jastrem has been president and CEO of
Exhibitgroup/Giltspur, a division of Viad Corp., since 2006. Previously, Mr. Jastrem was an
executive for eight years with Omnicom Group Inc., where he started in 1998 as chairman and CEO of
Rapp Collins Worldwide-Dallas (RCW), the global leader in direct response marketing and database
management. Prior to his tenure at Omnicom, Mr. Jastrem was president and CEO of TEAM Consultants,
which specialized in strategic planning, financing, interim management, technology-enabled
solutions, and mergers and acquisitions. Prior to joining TEAM Consultants, Mr. Jastrem served as a
member of the executive team at Knapp Communications Corporation (the publisher of Architectural
Digest and Bon Appetit magazines), and at Wickes Companies Inc., an international retailer and
manufacturer.
Mr. Jastrems experience as a chief executive officer and senior executive at large public
businesses, his experience as an entrepreneur in private organizations, and his strong background
in the areas of marketing, sales, corporate finance and strategic planning and management enable
him to provide valuable leadership and support to the Company in the areas of financial and
strategic planning, and also enable him to contribute meaningfully to the Audit Committee.
-3-
Table of Contents
Colin J. OBrien, 71, has served as a member of our board of directors since September 2008
and currently serves as a member of the Audit Committee. Prior to retiring in 2001, Mr. OBrien
was employed in various positions with Xerox Corporation from 1992-2001, including vice president
of Business Development and Systems Strategy, CEO of Xeroxs New Enterprise Board, and executive
chairman of XESystems Inc., a subsidiary of Xerox. In 1986, Mr. OBrien formed an investment
company with E.M. Warburg Pincus & Co. Inc., making a number of acquisitions in defense
electronics. Prior to that time, Mr. OBrien served as chairman and chief executive of Times Fiber
Communications Inc., a publicly traded company, and president of General Instruments cable
television operations. Mr. OBrien has held management positions with Union Carbide in both Canada
and Europe, and has served on a number of public and private boards.
Mr. OBriens experience as a public company chief executive officer and senior executive at
large public businesses, his experience serving on the boards of public companies, and his
background in mergers and acquisitions and corporate finance matters enable him to provide valuable
leadership and support to the Company in the areas of financial and strategic planning, and also
enable him to contribute meaningfully to the Audit Committee.
Warren E. Pinckert II, 66, has served as a member of our board of directors since February
2008 and currently serves as the chairman of the Audit Committee and as a member of the
Compensation Committee. Mr. Pinckert was the Chief Executive Officer of Cholestech Corporation, a
medical device company, from 1993 until its acquisition in 2007. Prior to joining Cholestech, Mr.
Pinckert served as Chief Financial Officer of Sunrise Medical, a durable medical equipment
manufacturer. Mr. Pinckert also served as a member of the board of directors of PacifiCare Health
Systems, a managed care company, until its acquisition in 2005. Since 2007, Mr. Pinckert has been
retired. Mr. Pinckert currently serves on the board or directors of an early stage medical device
company, BioVentrix Inc.
Mr. Pinckerts experience as a public company chief executive officer and chief financial
officer, his extensive SEC reporting and corporate governance experience, and his prior public
company board service enable him to provide valuable leadership and support to the Company in the
areas of financial reporting and corporate governance, and also render him well-suited to chair our
Audit Committee.
Michael Seedman, 54, has served as a member of our board of directors since August 2008 and
currently serves as a member of the Nominating Committee. Mr. Seedman is the founder of Seedman and
Associates, a private equity firm. He has more than 30 years of senior executive management,
leadership and technological innovation expertise and experience. Mr. Seedman was previously an
Industrial Partner with Ripplewood, where he served on the D&M Holdings Inc. board of directors. He
began his affiliation with Ripplewood as an Industrial Partner with Western Multiplex Corp.
(acquired by Proxim Corporation), where he served on its board of directors. Before his association
with Ripplewood, Mr. Seedman was the founder and Chairman of Entrega Technologies (acquired by
Xircom), a computer peripheral designer and manufacturer. Mr. Seedman was Vice President and
General Manager of U.S. Robotics Personal Communications Division (acquired by 3Com Corporation).
Prior to US Robotics, Mr. Seedman served as President and Chief Executive Officer of Practical
Peripherals, which he founded in 1981 and later sold to Hayes Microcomputer, Inc. Mr. Seedman
currently serves on the boards of directors of Revenew Systems, Inc., Cleversafe Inc., and LS
Research, LLC. His previous board affiliations have been with both public and private boards. Mr.
Seedman has served as an Executive Partner, a senior operating consultant role, to SAC PCG since
2007.
Mr. Seedmans technological expertise and experience, background in private equity,
entrepreneurial and leadership skills, previously held senior-executive leadership positions,
and experience serving on the boards of public companies, enable him to provide valuable
leadership and support to the Company in the areas of information technology and strategic
planning.
-4-
Table of Contents
Andrew E. Vogel, 37, has served as a member of our board of directors since September 2008 and
currently serves as a member of the Audit Committee. Mr. Vogel is a Managing Member of ZM Capital,
a media-focused private equity firm, and has been working at ZelnickMedia Corp. since late 2003.
Prior to joining ZelnickMedia, Mr. Vogel was an investment professional at Ripplewood Holdings.
Previously, Mr. Vogel was an associate at McCown De Leeuw & Co. and an investment banker in Lehman
Brothers Mergers and Acquisitions group. Mr. Vogel is also a director of ThinkMap Inc. Mr. Vogel
has a B.A. from Wesleyan University and an M.B.A. from Harvard Business School.
Mr. Vogels investment banking background and experience in private equity capital markets and
corporate finance matters enable him to provide valuable leadership and support to the Company in
the areas of financial and strategic planning, and also enable him to contribute meaningfully to
the Audit Committee.
Governance of the Company
Our business, property and affairs are managed by, or under the direction of, our board of
directors, which currently consists of 8 directors. Our board of directors maintains an Audit
Committee, a Nominating Committee and a Compensation Committee, each of which is discussed in
detail below.
Independence of Directors
Our common stock is listed on the Global Market of The NASDAQ Stock Market LLC (NASDAQ). We
qualify as a controlled company as defined in Rule 5615(c)(1) of the Marketplace Rules
(Marketplace Rules) of NASDAQ because more than 50% of our voting power is controlled by a single
shareholder, CBay, Inc. (CBay). As a controlled company, we are exempt from the requirements of
Rule 5605(b), (d) and (e) of the Marketplace Rules with respect to our board of directors being
comprised of a majority of independent directors and the related rules covering the independence
of directors serving on the Compensation Committee and the Nominating Committee of our board of
directors. The controlled company exemption does not modify the independence requirements of the
Audit Committee, which requires three independent directors. Our Audit Committee currently
consists of four independent directors (Messrs. Jastrem, OBrien, Vogel and Pinckert).
As required by the rules of the Securities and Exchange Commission (SEC), our board of
directors uses the independence requirements of NASDAQ (the Independence Requirements) to assess
the independence of each of its members. Our board of directors has determined that Messrs.
Pinckert, Jastrem, OBrien and Vogel are independent in accordance with the Independence
Requirements. In making its determinations, our board of directors did not consider any related
party transactions that are not discussed under Item 13, below the heading Related Party
Transactions.
Committees of our Board of Directors
Our board of directors maintains the following three standing committees: Audit Committee;
Compensation Committee; and Nominating Committee.
Audit Committee
The Audit Committee oversees our corporate accounting and financial reporting process. The
responsibilities of the Audit Committee, which are set forth in a written charter adopted by our
board of directors and available on our website at www.medquist.com, include:
| review and assess the adequacy of the Audit Committee and its charter at least annually; |
-5-
Table of Contents
| evaluate, determine the selection of, and if necessary, the replacement/rotation of, our independent registered public accounting firm; | ||
| ensure timely rotation of lead and concurring audit partner of our independent registered public accounting firm; | ||
| review our audited consolidated financial statements as well as our quarterly consolidated financial statements which are not audited; | ||
| review whether interim accounting policies and significant events or changes in accounting estimates were considered by our independent registered public accounting firm to have affected the quality of our financial reporting; | ||
| review our financial reports and other information submitted to any governmental body or the public; | ||
| review with management and our independent registered public accounting firm their judgments about the quality of disclosures in our consolidated financial statements; | ||
| obtain from our independent registered public accounting firm its recommendation regarding our internal control over financial reporting and review managements report on its assessment of the design and effectiveness of our internal control over financial reporting; | ||
| review managements report on its assessment of the design and effectiveness of our internal control over financial reporting; | ||
| review our major financial risk exposures; | ||
| pre-approve all audit and permitted non-audit services and related fees; | ||
| establish, review and update periodically our code of business conduct and ethics; | ||
| establish and review policies for approving related party transactions between us and our directors, officers or employees; | ||
| adopt procedures for receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters; and | ||
| adopt regular and separate systems of reporting to the Audit Committee by management and our internal auditors regarding controls and operations of business units. |
The Audit Committee (or disinterested members of our board of directors) is also responsible
for approving or ratifying all related party transactions. If the related party transaction
involves compensation, such transaction must also be approved by the Compensation Committee. The
Audit Committee is composed of Warren E. Pinckert II (Chair), John F. Jastrem, Colin J. OBrien and
Andrew E. Vogel. Messrs. Pinckert, Jastrem, OBrien and Vogel have been determined by our board of
directors to have met the Independence Requirements for the purposes of serving on the Audit
Committee. Our board of directors has determined that Mr. Pinckert is an audit committee
financial expert as that term is defined in Item 407(d)(5) of Regulation S-K.
-6-
Table of Contents
Compensation Committee
While our board of directors is responsible for determining and approving the compensation for
our executive officers in its sole discretion, including all individuals whose compensation is set
forth in the Summary Compensation Table under Item 11, it frequently solicits recommendations
from the Compensation Committee regarding the following:
| the corporate goals and objectives relevant to the compensation of our President and Chief Executive Officer and our other executive officers; | ||
| the performance of these officers in light of those goals and objectives; and | ||
| the compensation of these officers based on such evaluations. |
The Compensation Committee is composed of Robert Aquilina (Chair), Frank Baker, Peter Berger
and Warren Pinckert. The Compensation Committee does not have a written charter.
Nominating Committee
The responsibilities of the Nominating Committee, which are set forth in a written charter
adopted by our board of directors and available on our website at www.medquist.com, includes the
selection of potential candidates for our board of directors. The Nominating Committee also makes
recommendations to our board of directors concerning the membership of the other board committees
and is responsible for developing policies and procedures with regard to the consideration of any
director candidates recommended by our shareholders. The Nominating Committee is composed of Peter
Berger (Chair), Frank Baker and Michael Seedman.
Generally, our board of directors seeks diverse members who possess the background, skills and
expertise to make a significant contribution to our board of directors, us and our shareholders.
The Nominating Committee has adopted a set of procedures to guide it in the identification and
evaluation of director nominees. The Nominating Committee supports our view that the continuing
service of qualified incumbents promotes stability and continuity in the board room, contributing
to our board of directors ability to work as a collective body, while giving us the benefit of the
familiarity and insight into our affairs that our incumbent directors have accumulated during their
tenure. Accordingly, the process of the Nominating Committee for identifying director nominees
first considers re-nominating incumbent directors who continue to satisfy the Nominating
Committees criteria for membership on our board of directors, whom the Nominating Committee
believes continue to make important contributions to our board of directors and who consent to
continue their service on our board of directors.
If the Nominating Committee concludes new candidates are appropriate, it will review
appropriate biographical information about the proposed candidates considering the following
criteria, among others: personal and professional integrity, ethics and values; experience in
corporate management, such as serving as an officer or former officer of a publicly held company;
experience in our industry; experience as a board member of another publicly held company;
diversity of expertise and experience in substantive matters pertaining to our business relative to
other members of our board of directors; and practical and mature business judgment. The
Nominating Committee will also consider our board of directors overall balance of diversity of
perspectives, backgrounds and experiences. In seeking candidates, the Nominating Committee will
solicit suggestions from other members of our board of directors and our management and may also
engage the services of a professional search firm. The Nominating Committee will discuss and
consider the potential candidates and choose which candidates to recommend to our board of
directors.
-7-
Table of Contents
Candidates proposed by shareholders in accordance with the procedures set forth in our By-Laws
will be considered by the Nominating Committee under criteria similar to the evaluation of other
candidates, except that the Nominating Committee may consider, as one of the factors in its
evaluation of shareholder recommended nominees, the size and duration of the interest in our common
stock of the recommending shareholder or shareholder group. The Nominating Committee may also
consider the extent to which the recommending shareholder intends to continue holding its interest
in us, including, in the case of nominees recommended for election at an annual meeting of
shareholders, whether the recommending shareholder intends to continue holding its interest at
least through the time of such annual meeting.
Code of Business Conduct and Ethics
We have adopted a written code of business conduct and ethics which applies to all of our
directors, officers and other employees, including our principal executive officer, our principal
financial officer and our principal accounting officer. Our code of business conduct and ethics is
available on our website at www.medquist.com. Disclosure regarding any amendments to, or waivers
from, provisions of the code of business conduct and ethics that apply to our directors, principal
executive and financial and accounting officers will be included in a Current Report on Form 8-K
within four business days following the date of the amendment or waiver, unless web site posting of
such amendments or waivers is then permitted by the rules of NASDAQ.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires that each of our executive officers, directors and
persons who beneficially own more than 10% of our common stock file with the SEC reports of
ownership and changes in their ownership of our common stock. Our executive officers and directors
and beneficial owners of greater than 10% of our common stock are required by SEC regulations to
provide us with copies of all Section 16(a) forms that they file. Based solely on our review of
the copies of such forms furnished to us, we believe that for the year ended December 31, 2009, all
of our executive officers, directors and persons owning greater than 10% of our common stock
complied with all Section 16(a) filing requirements applicable to them, except Mark E. Schwarz, a
former director, failed to timely file two Form 4s reporting, in the aggregate, four transactions.
Executive Officers of the Company
Peter Masanotti, 55, has served as our Chief Executive Officer since September 2008 and as our
President since November 2008. Prior to joining us, Mr. Masanotti was managing director and global
head of Business Process Sourcing at Deutsche Bank since May 2007, where he was responsible for
offshore and onshore labor productivity and efficiency for the investment banking platform. From
July 2005 through May 2007, Mr. Masanotti was the Chief Operating Officer and Executive Vice
President of OfficeTiger LLC, a judgment-based business outsourcing firm which services major
investment banks and Fortune 500 companies. From December 2001 to May 2005, Mr. Masanotti served
as Chief Operating Officer of Geller & Company, a privately held finance and accounting outsourcing
firm.
Dominick Golio, 64, has served as our Chief Financial Officer since April 2009. Prior to
joining us, Mr. Golio was the North America Chief Financial Officer for D & M Holdings NA, a global
consumer electronics company and a Bain Capital Holdings Portfolio Company, from 2002 to April
2009, where he had direct involvement in all mergers and acquisitions activities. From 1993 to
2002, Mr. Golio was the Chief Financial Officer and Senior Vice President of Finance of Belco Oil &
Gas Corporation, an energy company previously listed on the New York Stock Exchange. From 1991 to
1993, Mr. Golio served as
-8-
Table of Contents
the Chief Financial Officer and Vice President of Finance of Millmaster Onyx Group, Inc., a
manufacturer of specialty chemicals and a portfolio company of RFE Investment Partners.
Michael F. Clark, 48, has served as our Chief Operating Officer since June 2009. Mr. Clark
previously served as our Senior Vice President of Operations from February 2005 to June 2009. Mr.
Clark joined us in 1998 through our acquisition of MRC. From November 2003 until February 2005,
Mr. Clark served as our Senior Vice President of Operations for our Western Division. From May
2002 until November 2003, Mr. Clark served as our Vice President of Operations for our Southwest
Division and from January 1998 until July 2000, he served as Region Vice President for the
Southeast. From May 2001 until May 2002, Mr. Clark served as Chief Operating Officer for eScribe,
a transcription service provider. While at MRC, Mr. Clark served as Vice President, Marketing and
Corporate Services.
Alan Gold, 58, has served as our Senior Vice President of Sales & Marketing since March 2009.
Prior to joining us, Mr. Gold was the Vice President of Sales, Managed Services, for Siemens
Medical Solutions from 2000 to 2008, where he was responsible for all sales and marketing
activities for Managed Services. From 1989 to 2000, Mr. Gold was employed by Shared Medical
Systems, where he served as the Vice President of Sales and New Ventures (1998 to 2000), Vice
President of Marketing (1996 to 1997), Area Vice President of Eastern Operations (1991 to 1995) and
Director of Sales Support (1989 to 1990).
Kevin Piltz, 51, has served as our Chief Information Officer since June 2009. Prior to
joining us, Mr. Piltz was the Chief Information Officer for Geller & Company, a privately held
finance and accounting outsourcing firm, from 2002 to 2009. From 1998 to 2002, Mr. Piltz was the
Chief Information Officer of ITDS, a provider of information solutions to the communications and IP
industry.
James Brennan, 62, has served as our Principal Accounting Officer, Controller, Treasurer and
Vice President since November 2006 and served as our Interim Principal Financial Officer from
November 2008 to April 2009. From March 2006 until his appointment as our Principal Accounting
Officer, Controller and Vice President, Mr. Brennan served as a consultant to us providing
Sarbanes-Oxley compliance and financial accounting services. Mr. Brennan has been operating his
own consulting firm, specializing in providing Sarbanes-Oxley compliance and financial accounting
services, since July 2005. Between May 2000 and July 2005, Mr. Brennan served as the Vice
President of Finance for two divisions of IKON Office Solutions. From 1995 to 1998, Mr. Brennan
served as Vice President and Business Unit Financial Officer for the GS Electric Division of
General Signal. From 1991 to 1995, Mr. Brennan served as Assistant Controller of General Signal
Corporation.
Mark R. Sullivan, 38, serves as our General Counsel, Chief Compliance Officer and Secretary.
Mr. Sullivan was appointed as General Counsel in September 2006, Chief Compliance Officer in July
2006 and Secretary in January 2005. From August 2004 until September 2006, Mr. Sullivan served as
our Acting General Counsel. Between March 2003 and August 2004, Mr. Sullivan served as our
Associate General Counsel and Assistant Secretary. Prior to joining us, Mr. Sullivan was in
private practice with Pepper Hamilton LLP from January 2000 until March 2003, and Drinker Biddle &
Reath LLP from August 1998 to January 2000.
We are not aware of any arrangements or understandings between any of the individuals listed
above and any other person pursuant to which he or she was or is to be selected as an officer,
other than any arrangements or understandings with our officers acting solely in their capacities
as such.
-9-
Table of Contents
ITEM 11. | EXECUTIVE COMPENSATION. |
Compensation Discussion and Analysis
Compensation Philosophy
We provide our executive officers, including our President and Chief Executive Officer (Mr.
Masanotti), with incentives tied to the achievement of our corporate objectives.
During the past few years, in making executive hiring and compensation decisions, we
considered the risks associated with our ongoing litigation and governmental investigation matters,
the change in our majority shareholder, and our board or directors decision not to provide
traditional equity-based long term incentives on an ongoing basis. During the past few years, we
experienced a significant turnover in our senior management. In light of all of these challenges,
our board of directors established a total compensation philosophy and structure designed to
accomplish the following objectives:
| attract, retain and motivate executives who can thrive in a competitive environment of continuous change and who can achieve positive business results in light of the challenges that we have faced and continue to face; | ||
| provide our executives with a total compensation package that recognizes individual contributions, as well as overall business results; and | ||
| promote and reward the achievement of objectives that our board of directors and management believe will lead to long-term growth in shareholder value, including the resolution of our ongoing litigation and governmental investigation matters. |
To achieve these objectives, we intend to maintain compensation arrangements that tie a
substantial portion of our executive officers overall compensation to the achievement of key
strategic, operational and financial goals.
Setting Executive Officer Compensation
Board of Directors, Compensation Committee and Management
While our board of directors is responsible for determining and approving the compensation of
our executive officers in its sole discretion, it frequently solicits recommendations from the
Compensation Committee regarding the following:
| the corporate and individual goals and objectives relevant to the compensation of our executive officers; | ||
| the evaluation of our corporate performance and the performance of our executive officers in light of such goals and objectives; and | ||
| the compensation of our executive officers based on such evaluations. |
On a going forward basis, our President and Chief Executive Officer, our Vice President of
Human Resources and the Compensation Committee together will review the performance of our
executive officers, other than Mr. Masanotti, and will provide our board of directors with the
results of the review and make recommendations to our board of directors for final approval with
respect to the compensation of our executive officers. Our board of directors currently is, and
will continue to be, responsible for
-10-
Table of Contents
setting the compensation of Mr. Masanotti and evaluating his performance based on corporate
goals and objectives.
The compensation for Mr. Masanotti is based on an agreement between us and Mr. Masanotti. The
terms of the agreement with Mr. Masanotti were negotiated and approved by our board of directors
and are described below under the caption Compensation of our President and Chief Executive
Officer.
Our executive officers do not play a role in their own compensation determination, other than
discussing individual performance objectives with our President and Chief Executive Officer.
Elements of Compensation
Our executive compensation program utilizes four primary elements to accomplish the objectives
described above:
| base salary; | ||
| annual cash incentives linked to corporate and individual performance; | ||
| long-term incentives; and | ||
| benefits and perquisites. |
We believe that we can meet the objectives of our executive compensation program by achieving
a balance among these four elements that is competitive with our industry peers and creates
appropriate incentives for our executive officers. Actual compensation levels are a function of
both corporate and individual performance as described under each compensation element below. In
making compensation determinations, the Compensation Committee and our board of directors consider
the competitiveness of compensation both in terms of individual pay elements and the aggregate
compensation package.
Base Salary
We provide our executive officers with base salary in the form of fixed cash compensation to
compensate them for services rendered during the fiscal year. Consistent with our compensation
philosophy, our board of directors believes that the current base salaries of our executive
officers are at levels competitive with similarly-sized public companies in the healthcare IT
sector (Peer Companies) with additional consideration given to the challenges we have and continue
to face.
The base salary of our executive officers is reviewed for adjustment annually by our board of
directors. Generally, in making a determination of whether to make base salary adjustments, our
board of directors considers the following factors:
| our success in meeting our strategic operational and financial goals; | ||
| our President and Chief Executive Officers assessment of such executive officers individual performance; | ||
| length of service to us of such executive officer; | ||
| changes in scope of responsibilities of such executive officer; and | ||
| the base salaries of executive officers at Peer Companies possessing similar job titles. |
-11-
Table of Contents
In addition, our board of directors considers internal equity within our organization and,
when reviewing the base salaries of our executive officers, their current aggregate compensation.
2009 Base Salaries
Our board of directors approved an increase in the base salary of Mr. Clark of 7.9% to
$250,000 for 2009, effective March 16, 2009. Mr. Clarks salary was increased because of his
individual achievements and high level of performance in 2008. Subsequently, in connection with
Mr. Clarks promotion from the position of Senior Vice President of Operations to Chief Operating
Officer, our board of directors increased Mr. Clarks base salary by 10% to $275,000 effective as
of June 1, 2009. No other base salary adjustments for our executive officers were made for 2009.
2010 Base Salaries
No base salary adjustments for our executive officers were made for 2010.
The 2010 base salaries of our executive officers are as follows:
2010 Annual Base | ||||
Name | Salary Rate ($) | |||
Peter Masanotti |
500,000 | |||
Kevin Piltz (1) |
280,000 | |||
Michael Clark |
275,000 | |||
Dominick Golio (2) |
275,000 | |||
Alan Gold (3) |
240,000 | |||
Mark R. Sullivan |
237,930 | |||
James Brennan |
221,450 |
(1) | Mr. Piltz was hired in May 2009 and his base salary is set forth in an employment agreement between him and us dated May 18, 2009. | |
(2) | Mr. Golio was hired in April 2009 and his base salary is set forth in an employment agreement between him and us dated April 9, 2009. | |
(3) | Mr. Gold was hired in March 2009 and his base salary is set forth in an employment agreement between him and us dated February 26, 2009. |
Annual Cash Incentive
We believe that performance-based cash incentives play an essential role to motivate our
executive officers to achieve defined annual goals. The objectives of our annual management
incentive plans are to:
| align the interests of executives and senior management with our strategic plan and critical performance goals; | ||
| motivate and reward achievement of specific, measurable annual individual and corporate performance objectives; | ||
| provide payouts commensurate with our performance; | ||
| provide competitive total compensation opportunities; and |
-12-
Table of Contents
| enable us to attract, motivate and retain talented executive management. |
2009 Management Incentive Plan
The Compensation Committee recommended, and our board of directors approved, our 2009
Management Incentive Plan (2009 Plan) in January 2009.
Participation; Eligibility. Select key management level employees were eligible to
participate in our 2009 Plan, including each of the executive officers identified above. Other
criteria for participation and eligibility to receive an incentive reward under the 2009 Plan
included the following:
| a participant must have received a performance rating of solid performer or better for 2009 to receive an incentive award; and | ||
| a participant must have been an active employee as of the award payout date to receive an incentive award. |
Incentive Targets. Each of our executive officers was eligible to receive a target annual
cash incentive award expressed as a percentage of his or her base salary for 2009 (Target
Incentive). The table below entitled Grants of Plan-Based Awards (and, specifically, the
information under the caption Estimated Possible Payouts Under Non-Equity Incentive Plan Awards)
illustrates the threshold, target and maximum amounts of cash incentives that were potentially
payable to our named executive officers with respect to 2009 performance under the 2009 Plan.
Performance Measures under the 2009 Plan. Payment of incentive awards were based on a
combination of corporate and individual performance objectives which were established for each of
our executive officers as a way to communicate our expectations and to maintain and unify our
executives focus on our key strategic objectives, as well as to measure performance. The actual
net revenues and EBITDA targets under the 2009 Plan and the individual performance objectives for
each executive officer under the 2009 Plan were based on certain internal financial goals set in
connection with our board of directors consideration and approval of our annual operating plan for
2009. The objectives were based on the following criteria:
| 30% upon the achievement of such executive officers 2009 individual performance objectives; | ||
| 35% based upon a 2009 net revenues target; and | ||
| 35% based upon a 2009 EBITDA target. |
2010 Management Incentive Plan
The Compensation Committee recommended, and our board of directors approved, our 2010
Management Incentive Plan (2010 Plan) on January 21, 2010, however the exact criteria for each
executive officers cash incentive award has not yet been determined. Our Compensation Committee
and board of directors are in the process of finalizing such criteria following our acquisition of
substantially all of the assets of the domestic business of Spheris, Inc. and certain of its
affiliates on April 22, 2010.
The terms of the 2010 Plan are substantially similar to the terms of the 2009 Plan.
Individual performance objectives for the 2010 Plan will be set in the same manner as they were set
in 2009. Target Incentive amounts under the 2010 Plan remain unchanged from the 2009 Plans for all
of our executive officers. The financial performance targets under the 2010 Plan and the
individual performance
-13-
Table of Contents
objectives for each executive officer under the 2010 Plan will be based on certain internal
financial goals set in connection with our board of directors consideration and approval of our
annual operating plan for 2010.
We believe that the internal financial goals, although not guaranteed, will be capable of
being achieved if our executive officers meet or exceed their individual objectives, if we perform
according to our 2010 annual operating plan and if the assumptions in our 2010 annual operating
plan are proven correct.
Long-Term Incentives
Equity-Based Incentives
On September 30, 2008 (Grant Date), we made a stock option grant (Original Stock Option Grant)
to Mr. Masanotti to purchase up to 295,749 shares of our common stock at the fair market value of
our common stock as of September 30, 2008, which was $4.85 per share, with the options expiring on
September 30, 2018. The number of shares that Mr. Masanotti was granted an option to purchase was
provided for in Mr. Masanottis Employment Agreement with us dated September 3, 2008 (Masanotti
Employment Agreement). On March 2, 2009, we entered into an Amended and Restated Stock Option
Agreement with Mr. Masanotti (Amended Masanotti Option Agreement), to (i) amend the exercise price
of the Original Stock Option Grant and (ii) to provide that if Mr. Masanottis employment by us or
one of our subsidiaries is terminated by us for cause as defined in the Masanotti Employment
Agreement, the option will terminate immediately in full whether or not vested or exercisable. The
Amended Masanotti Option Agreement provides, among other things, that:
| the exercise price shall be equal to the higher of (i) the fair market value of the Companys common stock as of the Grant Date or (ii) $8.25. The fair market value of our common stock (as reported by NASDAQ) on the Grant Date was $4.85, accordingly the exercise price is $8.25; | ||
| one-third (1/3) of the shares subject to the option vest on the first anniversary of the Grant Date and, thereafter, one-sixth (1/6) of the shares subject to the option vest on each of the following: the date that is six months after the first anniversary of the Grant Date, the second anniversary of the Grant Date, the date that is six months after the second anniversary of the grant date, and the third anniversary of the Grant Date; | ||
| upon the occurrence of a change in control or our termination of Mr. Masanottis employment by us without cause or by him for good reason (each, as defined in the Masanotti Employment Agreement), the options shall become immediately exercisable, to the extent not already vested; and | ||
| in the event of termination of Mr. Masanottis employment for any reason other than without cause by us, or for good reason by him, any of the unvested options shall be immediately forfeited. |
In
June 2004, our board of directors decided not to provide traditional equity-based long term
incentives until we became current in our reporting obligations under the Exchange Act.
Accordingly, from June 2004 until we became current in our reporting obligations under the Exchange
Act in 2007, we suspended the granting of any stock options. Messrs. Sullivan and Clark received
grants of stock options as part of their compensation prior to the decision by our board of
directors on June 2004 to not provide traditional
-14-
Table of Contents
equity-based long term incentives. Such grants, to the extent they have not expired, are
shown below in the under the heading Outstanding Equity Awards at Fiscal Year-End.
2009 Long Term Incentive Plan
In August 2009 our board of directors adopted a long-term incentive plan (LTIP) for certain
members of our senior management team. The LTIP is administered by the Compensation Committee and
is designed to encourage and reward the creation of long-term equity value by certain members of
our senior management team. Effective as of January 1, 2009, certain executives and key employees
who will be selected by the Compensation Committee became eligible to participate in the LTIP.
Cash payments pursuant to the LTIP will be made in three equal annual installments during the three
years following the expiration of the LTIPs term (December 31, 2011). As of April 30, 2010, no
selection of the executives or key employees eligible for participation in the LTIP have been made
and no awards under the LTIP have been made.
Severance and Retention Agreements
Employment Agreement Severance
The severance arrangements applicable to Messrs. Masanotti, Golio, Piltz, Sullivan, Clark and
Brennan are set forth in each of their respective employment agreements, as discussed in detail
below under the heading Potential Payments Upon Termination or Change in Control.
Benefits and Perquisites
Benefits
We maintain broad-based benefits that are provided to all full-time employees, including
health and dental insurance, life and disability insurance and our 401(k) plan. Certain of these
benefits require employees to pay a portion of the premium. These benefits are offered to our
executive officers on the same basis as all other employees, except that we provide, and pay the
premiums for, additional long term disability and life insurance coverage for such executive
officers.
We also maintained a deferred compensation plan for certain of our employees (Deferred
Compensation Plan). In the third quarter of 2009 we terminated the Deferred Compensation Plan and
distributed plan assets to members and liquidated the plan assets. The Deferred Compensation Plan
was administered by the Compensation Committee and previously allowed certain members of management
and other highly compensated employees to defer a certain percentage of their income. Our board
of directors indefinitely suspended the Deferred Compensation Plan in June 2004. Mr. Sullivan was
our only executive officer who participated in the Deferred Compensation Plan while it was active
and was our only executive officer with an account balance in our Deferred Compensation Plan prior
to its termination. Information regarding Mr. Sullivans participation in the Deferred
Compensation Plan is described below under Nonqualified Deferred Compensation.
Perquisites or Other Personal Benefits.
Our executive officers are entitled to few perquisites or other personal benefits that are not
otherwise available to all of our employees. In 2009, we provided premium payments for additional
long term disability and life insurance coverage to our executive officers.
Additional compensation provided to Mr. Masanotti (including certain travel and lodging
expenses) are detailed below under the heading Summary Compensation Table.
-15-
Table of Contents
These perquisites or other personal benefits represent a relatively modest portion of each
executive officers compensation. We do not anticipate any significant changes to the perquisites
or other personal benefits levels of our executive officers for 2010.
Compensation of our President and Chief Executive Officer
Compensation of Mr. Masanotti, our President and Chief Executive Officer
In connection with his appointment as our Chief Executive Officer, we entered into an
employment agreement with Mr. Masanotti, dated as of September 3, 2008 (Masanotti Employment
Agreement), pursuant to which Mr. Masanotti will serve as our Chief Executive Officer through
December 31, 2011. Our board of directors is responsible for monitoring and reviewing the
performance of Mr. Masanotti on an ongoing basis.
In structuring Mr. Masanottis compensation, our board of directors considered the importance
of motivating a new Chief Executive Officer to make a long-term commitment to us and to
consistently grow our business. Based on these and other considerations, our board of directors
approved compensation for Mr. Masanotti comprised of a sign-on bonus, base salary, cash bonus and
equity incentives. Pursuant to the terms of his employment agreement, Mr. Masanotti was entitled
to receive up to $800,000 on February 1, 2009 as a sign-on bonus. Due to the amount of the bonus
payment relating to the 2008 fiscal year that Mr. Masanotti received from his prior employer (Prior
Employer Bonus), in accordance with the terms of the Masanotti Employment Agreement, our obligation
to pay any portion of the sign-on bonus on February 1, 2009 was eliminated.
In addition, Mr. Masanotti will receive an annual base salary of $500,000 and an annual bonus
award based upon the achievement of target performance objectives established by our board of
directors, equal to up to 140% of his base salary, or $700,000 based upon his current base salary.
The Masanotti Employment Agreement provides that Mr. Masanottis target performance objectives will
be established by our board of directors within the first three months of each fiscal year during
the term of his employment agreement. Our board of directors believes that the target performance
objectives to be established, although not guaranteed, will be capable of being achieved if Mr.
Masanotti meets or exceeds his individual objectives, if we perform according to our operating
plans and if the assumptions in our operating plans prove correct.
Pursuant to the terms of the Masanotti Employment Agreement, Mr. Masanotti received a stock
option grant from us to purchase up to 295,749 shares of our common stock. See Long-Term
Incentives Equity-Based Incentives above, for additional information regarding the stock option
grant to Mr. Masanotti.
Tax and Accounting Considerations Affecting Executive Compensation
We structure our compensation program in a manner that is consistent with our compensation
philosophy and objectives. However, while it is the Compensation Committee and our board of
directors general intention to design the components of our executive compensation program in a
manner that is tax efficient for both us and our executives, there can be no assurance that the
Compensation Committee or our board of directors will always approve compensation that is tax
advantageous for us.
We endeavor to design our equity incentive awards conventionally, so that they are accounted
for under standards governing equity-based arrangements and, more specifically, so that they are
afforded fixed treatment under those standards.
-16-
Table of Contents
Report of the Compensation Committee
We, the Compensation Committee of the board of directors of MedQuist Inc., have reviewed and
discussed the Compensation Discussion and Analysis set forth above with management and, based on
such review and discussions, we recommend to the board of directors that the Compensation
Discussion and Analysis set forth above be included in this Annual Report on Form 10-K.
Compensation Committee of the Board of Directors:
Robert Aquilina, Chairman
Frank Baker
Peter E. Berger
Warren E. Pinckert II
Frank Baker
Peter E. Berger
Warren E. Pinckert II
The preceding Report of the Compensation Committee shall not be deemed to be incorporated by
reference into any filing made by us under the Securities Act or the Exchange Act, notwithstanding
any general statement contained in any such filing incorporating this report by reference, except
to the extent we incorporate such report by specific reference.
-17-
Table of Contents
Summary Compensation Table
The following table sets forth, for the year ended December 31, 2009, summary information
concerning compensation of (i) all individuals who served as our Chief Executive Officer during the
fiscal year ended December 31, 2009; (ii) all individuals who served as our Chief Financial Officer
during the fiscal year ended December 31, 2009; (iii) our most highly compensated executive
officers during the fiscal year ended December 31, 2009, other than those who served as our Chief
Executive Officer and Chief Financial Officer, who were serving as executive officers as of
December 31, 2009; and (iv) one additional individual, who was one of our three most highly
compensated executive officers in 2009 but was not serving as an executive officer as of December
31, 2009 (collectively, the named executive officers).
Non-Equity | ||||||||||||||||||||||||||||
Option | Incentive Plan | All Other | ||||||||||||||||||||||||||
Name and | Salary | Bonus | Awards(1) | Compensation(2) | Compensation(3) | Total | ||||||||||||||||||||||
Principal Position | Year | ($) | ($) | ($) | ($) | ($) | ($) | |||||||||||||||||||||
Peter Masanotti, |
2009 | 500,000 | | | 700,000 | 7,258 | 1,207,258 | |||||||||||||||||||||
President and Chief |
2008 | 125,000 | | 65,721 | | 3,118 | 193,839 | |||||||||||||||||||||
Executive
Officer (4) |
||||||||||||||||||||||||||||
Dominick Golio, |
2009 | 186,506 | | | 137,500 | 9,321 | 333,327 | |||||||||||||||||||||
Senior Vice President and Chief Financial Officer (5) |
||||||||||||||||||||||||||||
James Brennan, |
2009 | 221,450 | | | 62,151 | 1,510 | 285,110 | |||||||||||||||||||||
Principal Accounting Officer, |
2008 | 219,569 | | | 66,435 | 1,741 | 287,745 | |||||||||||||||||||||
Controller, Treasurer and Vice President (6)(7) |
||||||||||||||||||||||||||||
Mark R. Sullivan, |
2009 | 237,930 | | | 108,193 | 1,605 | 347,728 | |||||||||||||||||||||
General Counsel, Chief |
2008 | 235,909 | 155,926 | | 107,069 | 1,836 | 500,740 | |||||||||||||||||||||
Compliance Officer and |
2007 | 229,250 | 25,000 | 31,185 | 7,272 | 292,707 | ||||||||||||||||||||||
Secretary |
||||||||||||||||||||||||||||
Michael Clark, |
2009 | 258,979 | | | 118,929 | 1,687 | 379,595 | |||||||||||||||||||||
Chief Operating Officer; and |
2008 | 229,781 | 151,876 | | 119,469 | 1,808 | 502,934 | |||||||||||||||||||||
Senior Vice President of Operations (6) |
||||||||||||||||||||||||||||
Kevin Piltz, |
2009 | 163,333 | | | 140,000 | 2,547 | 305,880 | |||||||||||||||||||||
Senior Vice President and Chief Information Officer (8) |
(1) | The amount in this column reflects the aggregate grant date fair value of the option awards calculated in accordance with FASB ASC Topic 718. Please see Note 13 to the Notes to our financial statements included in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on March 12, 2010, for a discussion of the assumptions used in determining the fair value calculation of each option award. | |
As discussed in Long-Term Incentives Equity-Based Incentives above, on September 30, 2008 (Grant Date), we made a stock option grant (Original Stock Option Grant) to Mr. Masanotti, to purchase up to 295,749 shares of our common stock at the fair market value of the our common stock as of September 30, 2008, which was $4.85 per share, with the options expiring on |
-18-
Table of Contents
September 30, 2018. On March 2, 2009, we entered into an Amended and Restated Stock Option Agreement with Mr. Masanotti (Amended Masanotti Option Agreement), to, among other things, amend the exercise price of the Original Stock Option Grant. The Amended Masanotti Option Agreement provides, among other things, that the option price is equal to the higher of (i) the fair market value of the Companys common stock as of the Grant Date or (ii) $8.25. The fair market value of our common stock (as reported by NASDAQ) on the Grant Date was $4.85, accordingly the exercise price is $8.25. The amendment of the exercise price of the Original Stock Option Grant did not result in any incremental fair value over what was reported for Mr. Masanotti in 2008 under the column Option Awards. | ||
(2) | The amounts in this column represent payments made pursuant to our 2009 Plan. | |
(3) | The amounts reported in this column for 2009 represent the following: |
Long Term | ||||||||||||||||
Group Life | Disability | |||||||||||||||
Insurance | Insurance | Other | ||||||||||||||
Premium Cost | Premium Cost | Perquisites(a) | ||||||||||||||
Name | ($) | ($) | ($) | Total | ||||||||||||
Peter Masanotti |
1,039 | 1,028 | 5,191 | 7,258 | ||||||||||||
Dominick Golio |
526 | 740 | 8,055 | 9,321 | ||||||||||||
James Brennan |
624 | 886 | 1,510 | |||||||||||||
Mark R. Sullivan |
653 | 952 | | 1,605 | ||||||||||||
Michael Clark |
708 | 979 | 1,687 | |||||||||||||
Kevin Piltz |
411 | 525 | 1,611 | 2,547 |
(a) | This amount consists of reimbursements paid to Messrs. Masanotti, Golio and Piltz for lodging expenses by each of them in connection with their employment in 2009. |
(4) | Mr. Masanottis employment with us commenced on September 16, 2008. | |
(5) | Mr. Golios employment with us commenced on April 13, 2009. | |
(6) | With respect to Messrs. Brennan and Clark, information for the fiscal year ended December 31, 2007 is omitted because neither Mr. Brennan nor Mr. Clark was a named executive officer in our definitive proxy statement that was filed with the SEC in December 2008. | |
(7) | Mr. Brennan served as our Interim Principal Financial Officer from November 21, 2008 through April 13, 2009. Mr. Brennan relinquished his role as Interim Principal Financial Officer upon Mr. Golio taking the position of Chief Financial Officer on April 13, 2009. Mr. Brennan continues to serve as our Principal Accounting Officer, Controller, Treasurer and Vice President. | |
(8) | Mr. Piltzs employment with us commenced in May 18, 2009. |
-19-
Table of Contents
Grants of Plan-Based Awards
The following table sets forth each grant of an award made to each named executive
officer for the year ended December 31, 2009.
Estimated Possible Payouts Under | ||||||||||||
Non-Equity Incentive Plan Awards(1) | ||||||||||||
Threshold | Target | Maximum | ||||||||||
Name | ($) | ($) | ($) | |||||||||
Peter Masanotti |
| 700,000 | | |||||||||
Dominick Golio(2) |
| 137,500 | 233,750 | |||||||||
James Brennan |
19,931 | 66,435 | 112,940 | |||||||||
Mark R. Sullivan |
32,121 | 107,069 | 182,016 | |||||||||
Michael Clark |
35,302 | 117,672 | 200,043 | |||||||||
Kevin Piltz(2) |
42,000 | 140,000 | 238,000 |
(1) | Includes the 2009 threshold, target and maximum payouts designated under the 2009 Plan discussed above in the Compensation Discussion and Analysis section. We achieved 97.3% of the net revenues target and 110% of the EBITDA target established exclusively for the 2009 Plan. Each named executive officer was determined to have fully achieved his individual performance objectives, other than Mr. Brennan. Messrs. Sullivan and Clark received 101% of their Target Incentive under the 2009 Plan. Messrs. Masanotti, Golio and Piltz received 100% of their Target Incentive under the 2009 Plan. Mr. Brennan received 94% of his Target Incentive under the 2009 Plan. The named executives that received payments under the 2009 Plan were: Mr. Masanotti ($700,000), Mr. Golio ($137,500), Mr. Brennan ($62,151), Mr. Sullivan ($108,193), Mr. Clark ($118,929); and Mr. Piltz ($140,000) and such payments were made on March 15, 2010. | |
(2) | The payment of 100% of the Target Incentive amounts for Messrs. Golio and Piltz were guaranteed and calculated as though they had been employed for all of 2009 at their base salary levels. |
Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table
We have or had written employment agreements with each of our named executive officers that
provide or provided for the payment of base salary and for each named executive officers
participation in our bonus programs and employee benefit plans.
As discussed in Long-Term Incentives Equity-Based Incentives above, on September 30, 2008
(Grant Date), we made a stock option grant (Original Stock Option Grant) to Mr. Masanotti, to
purchase up to 295,749 shares of our common stock at the fair market value of the our common stock
as of September 30, 2008, which was $4.85 per share, with the options expiring on September 30,
2018. On March 2, 2009, we entered into an Amended and Restated Stock Option Agreement with Mr.
Masanotti (Amended Masanotti Option Agreement), to, among other things, amend the exercise price of
the Original Stock Option Grant. The Amended Masanotti Option Agreement provides, among other
things, that the option price is equal to the higher of (i) the fair market value of the Companys
common stock as of the Grant Date or (ii) $8.25. The fair market value of our common stock (as
reported by NASDAQ) on the Grant Date was $4.85, accordingly the exercise price is $8.25.
-20-
Table of Contents
In addition, each agreement specifies payments and benefits that would be due to such named
executive officer upon the termination of his employment with us. See Potential Payments Upon
Termination or Change-In-Control below, for additional information regarding amounts payable upon
termination to each of our named executive officers.
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth all outstanding equity awards held by each of our named
executive officers as of December 31, 2009.
Number of Securities Underlying | ||||||||||||||||
Unexercised Options (#) | Option Exercise | Option Expiration | ||||||||||||||
Name | Exercisable | Unexercisable | Price | Date | ||||||||||||
Peter Masanotti |
98,583 | 197,166 | (4) | $ | 8.25 | (5) | September 30, 2018 | |||||||||
James Brennan |
| | | | ||||||||||||
Mark R. Sullivan |
2,500 | (1) | | $ | 16.21 | March 17, 2013 | ||||||||||
Michael Clark |
20,000 | (2) | $ | 27.89 | May 29, 2012 | |||||||||||
9,000 | (3) | | $ | 17.45 | February 4, 2013 | |||||||||||
Dominick Golio |
| | | | ||||||||||||
Kevin Piltz |
| | | | ||||||||||||
(1) | Options vested in full on March 13, 2008. | |
(2) | Options vested in full on May 29, 2007. | |
(3) | Options vested in full on February 4, 2008. | |
(4) | 98,583 of the shares subject to the option vest on September 30, 2009 and, thereafter, 49,292 of the shares vest on March 31, 2010, 49,291 of the shares vest on September 30, 2010, 49,291 of the shares vest on March 31, 2011 and 49,291 of the shares vest on September 30, 2011. | |
(5) | As discussed in Long-Term Incentives Equity-Based Incentives above, on September 30, 2008 (Grant Date), we made a stock option grant to Mr. Masanotti, to purchase up to 295,749 shares of our common stock at the fair market value of the our common stock as of September 30, 2008, which was $4.85 per share, with the options expiring on September 30, 2018. On March 2, 2009, we entered into the Amended Masanotti Option Agreement with Mr. Masanotti, to, among other things, amend the exercise price of the stock option grant. The Amended Masanotti Option Agreement provides, among other things, that the option price is equal to the higher of (i) the fair market value of the Companys common stock as of the Grant Date or (ii) $8.25. The fair market value of our common stock (as reported by NASDAQ) on the Grant Date was $4.85, accordingly the exercise price is $8.25. |
-21-
Table of Contents
Option Exercises and Stock Vested During Last Fiscal Year
There were no option exercises by any of our named executive officers during the year ended
December 31, 2009.
Pension Benefits
None of our named executive officers participate in or have account balances in qualified or
non-qualified defined benefit plans that provide for payments or other benefits at or in connection
with retirement sponsored by us.
Nonqualified Deferred Compensation
Prior to June 2004, participants in our Deferred Compensation Plan could defer up to 15% of
their base salary and up to 90% of any bonus compensation into an account in which the proceeds
would be available to the participant after termination of employment or prior to termination of
employment after the participant reaches the age of 65. Upon enrollment, the participant could
elect the method and timing of distributions in the participants enrollment agreement. All
deferred amounts increase or decrease based on hypothetical investment results of the participants
selected investment alternatives. Our board of directors indefinitely suspended the Deferred
Compensation Plan in June 2004. Mr. Sullivan is our only named executive officer who participated
in the Deferred Compensation Plan while it was active.
Mr. Sullivan is the only one of our named executive officers who had an account balance in our
Deferred Compensation Plan. Information related to Mr. Sullivans deferred compensation account
balances is provided below. None of the amounts shown in the table below appear in the Summary
Compensation Table for Mr. Sullivan.
Aggregate | ||||||||||||||||||||
Executive | Withdrawals/ | Aggregate Balance | ||||||||||||||||||
Contributions in | Our Contributions | Aggregate Earnings | Distributions in | at December 31, | ||||||||||||||||
Name | 2009 ($) |
in 2009 ($) |
in 2009 ($) |
2009 ($) |
2009 ($) |
|||||||||||||||
Mark R. Sullivan |
| | (5 | ) | 2,216 | |
In the third quarter of 2009 we terminated the Deferred Compensation Plan and distributed
plan assets to members, including Mr. Sullivan, who received a balance of $2,216.
Potential Payments Upon Termination or Change-In-Control
The following is a discussion of payments and benefits that would be due to each of our named
executive officers, upon the termination of his or her employment with us. The amounts in the
table below assume that each termination was effective as of December 31, 2009 and are merely
illustrative of the impact of a hypothetical termination of each executives employment. The
amounts to be payable upon an actual termination of employment can only be determined at the time
of such termination based on the facts and circumstances then prevailing.
Severance Payments
Mr. Masanotti
Under the terms of our employment agreement with Mr. Masanotti, he will be entitled to the
continuation of his then current base salary for a period of 12 months in the event that:
-22-
Table of Contents
| his employment is terminated by us without cause (as defined below), | ||
| he resigns for good reason (as defined below), or | ||
| we elect not to extend the term of Mr. Masanottis employment beyond the initial term or any of the automatic one-year extensions following the initial term of the employment agreement.. |
In order to receive the severance payments described herein, Mr. Masanotti is required to
execute and deliver a general release of claims against us.
As used in Mr. Masanottis employment agreement with us, the term cause means the occurrence
of any of the following: (1) his failure to substantially perform his duties set forth in the
employment agreement (other than as a result of total or partial incapacity due to physical or
mental illness) for a period of 15 days following written notice by us to him of such failure, (2)
dishonesty in the performance of his duties hereunder, (3) his conviction of, or plea of nolo
contendere to a crime constituting (x) a felony under the laws of the United States or any state
thereof or (y) a misdemeanor involving moral turpitude, (4) his willful malfeasance or willful
misconduct in connection with his duties set forth in the employment agreement or any willful act
or omission which is demonstrably injurious to our financial condition or business reputation or
any of our subsidiaries or affiliates or (5) his breach of the provisions in the employment
agreement relating to non-competition, confidentiality and our intellectual property.
As used in Mr. Masanottis employment agreement with us, the term good reason means (1) the
failure of us to pay or cause to be paid his base salary or annual bonus, when due pursuant to the
terms of the employment agreement, (2) any reduction in his base salary or annual bonus opportunity
set forth in the employment agreement, (3) any substantial and sustained diminution in his
authority, title, reporting relationship or responsibilities from those described in the employment
agreement, or (4) our material breach of the employment agreement; provided that any of the
foregoing events shall constitute good reason only if we fail to cure such event within 30 days
after receipt from Mr. Masanotti of written notice of the event which constitutes good reason;
provided, further, that good reason shall cease to exist for an event on the 60th day
following the later of its occurrence or Mr. Masanottis knowledge thereof, unless he has given us
written notice thereof prior to such date.
Mr. Masanotti is bound by certain non-competition and non-solicitation covenants which extend
for a period of 12 months following termination of his employment for any reason.
Messrs. Golio, Piltz, Brennan, Sullivan and Clark
Under the terms of their respective employment agreements, each of Messrs. Golio and Brennan
will be entitled to continuation of his then current base salary for a period of 12 months in the
event he is terminated without cause (as defined below).
Under the terms of our employment agreement with Mr. Piltz, he will be entitled to
continuation of his then current base salary for a period of 6 months in the event he is terminated
without cause.
Under the terms of their respective employment agreements, each of Messrs. Sullivan and Clark
will be entitled to the continuation of his then current base salary for a period of 12 months in
the event he is terminated without cause or if he tenders his written resignation within 30 days
following a substantial and material diminution of his duties or a reduction in his base salary in
excess of 10%, which diminution or reduction is not cured by us within 10 days of receiving his
written resignation.
-23-
Table of Contents
In order to receive the severance payments described above, each named executive officer is
required to execute and deliver a general release of claims against us.
As used in their respective employment agreements, the term cause means the occurrence of
any of the following: (1) such named executive officers refusal, willful failure or inability to
perform (other than due to illness or disability) his employment duties or to follow the lawful
directives of his superiors; (2) misconduct or gross negligence by such named executive officer in
the course of employment; (3) conduct of such named executive officer involving fraud,
embezzlement, theft or dishonesty in the course of employment; (4) a conviction of or the entry of
a plea of guilty or nolo contendere to a crime involving moral turpitude or that otherwise could
reasonably be expected to have an adverse effect on our operations, condition or reputation; (5) a
material breach by such named executive officer of any agreement with or fiduciary duty owed to us
or (6) alcohol abuse or use of controlled drugs other than in accordance with a physicians
prescription.
Applicable Restrictive Covenants
Mr. Brennan is bound by certain non-competition and non-solicitation covenants which extend
for a period of two years following termination of his employment for any reason. Messrs. Golio,
Piltz, Sullivan and Clark are bound by substantially similar covenants for a period of 12 months
following termination of their employment for any reason.
Assuming a termination without cause had occurred on December 31, 2009 (the last business
day of 2009), the payments to each of Messrs. Masanotti, Brennan, Sullivan, Clark, Golio and Piltz,
had an estimated value of:
Accelerated Vesting | ||||||||||||
Option | ||||||||||||
Salary Continuation | Grants(1) | |||||||||||
Name | ($) | ($) | Total ($) | |||||||||
Peter Masanotti |
500,000 | | 500,000 | |||||||||
James Brennan |
221,450 | | 221,450 | |||||||||
Mark R. Sullivan |
237,930 | | 237,930 | |||||||||
Michael Clark |
275,000 | | 229,781 | |||||||||
Dominick Golio |
275,000 | | 275,000 | |||||||||
Kevin Piltz |
140,000 | | 140,000 |
(1) | For purposes of the table above, we have assumed that the named executive officer experienced an involuntary termination without cause on December 31, 2009. Pursuant to the terms of the stock option grant to Mr. Masanotti, in that hypothetical scenario the accelerated options would have become immediately exercisable. As discussed in Long-Term Incentives Equity-Based Incentives above, on September 30, 2008 (Grant Date), we made a stock option grant to Mr. Masanotti, to purchase up to 295,749 shares of our common stock at the fair market value of the our common stock as of September 30, 2008, which was $4.85 per share, with the options expiring on September 30, 2018. On March 2, 2009, we entered into the Amended Masanotti Option Agreement with Mr. Masanotti, to, among other things, amend the exercise price of the stock option grant. The Amended Masanotti Option Agreement provides, among other things, that the option price is equal to the higher of (i) the fair market value of the Companys common stock as of the Grant Date or (ii) $8.25. The fair market value of our common stock (as reported by NASDAQ) on the Grant Date was $4.85, accordingly the exercise price is $8.25.The closing price per share of our common stock on December 31, 2009 was $6.69. Because the closing price per share of our common stock on December 31, 2009 ($6.69) was less than the exercise price per share of the option grant to Mr. Masanotti ($8.25), the value of the option grant to Mr. Masanotti was zero as of the first day the option grant to Mr. Masanotti would be exercisable. |
-24-
Table of Contents
Mr. Brennan has not received any stock option grants from us and the stock option grants to Messrs. Sullivan and Clark fully vested prior to December 31, 2009. |
Policies and Practices Related to Risk Management
We have initiated an ongoing assessment of our compensation practices in light of the risks in
our operations including, among other things, a review of managements decision-making and
policy-making structures and practices; the methodology used to define, update, and measure
short-term and long-term objectives as part of our management incentive and sales force commission
programs; the effectiveness and nature of communications within the Company and between management
and our board of directors and various committees; and our compliance policies, practices, and
programs. We believe that our compensation practices do not provide undue incentives, or are
reasonably likely, to expose the Company to material risk.
Compensation Committee Interlocks and Insider Participation
The current members of our Compensation Committee are Robert Aquilina (Chair), Frank Baker,
Peter Berger and Warren Pinckert. No member of our Compensation Committee was an officer or
employee of ours. In addition, there are no Compensation Committee interlocks between us and other
entities involving our executive officers and our board members who serve as executive officers of
those other entities.
Compensation of Directors
We currently do not pay Robert Aquilina, Frank Baker, Peter Berger and Michael Seedman,
each of whom is affiliated with our majority owner, CBay, any compensation for their service on our
board of directors. All directors are reimbursed for all reasonable expenses incurred by them in
connection with their service on our board of directors. Our former independent directors, Brian
ODonoghue and Mark Schwarz and our current independent directors, Messrs. Pinckert, Jastrem,
OBrien and Vogel, received the following annual compensation, prorated for Messrs. ODonoghue and
Schwarz through the date of their removal as directors on August 19, 2009 and prorated for Messrs.
Pinckert, Jastrem, OBrien, and Vogel through October 31, 2009:
Annual Board Retainer
|
$90,000 to be paid in equal installments of: | |
a non-refundable payment of $45,000
payable on February 15th of each year
(for service period of February 15th
to
August 14th) |
||
a non-refundable payment of $45,000
payable on August 15th of each year
(for service period of August 15th to
February 14th) |
||
Board Meeting Fees
|
$2,000 for meetings attended in person | |
$1,000 for meetings attended by phone | ||
Committee Chair Retainers
|
Audit Committee $15,000 | |
Compensation Committee $7,500 | ||
Nominating Committee $5,000 | ||
Special Committee $5,000 | ||
Committee Meeting Fees
|
$1,000 for meetings attended in person | |
(All Committees)
|
$500 for meetings attended by phone |
-25-
Table of Contents
Effective November 1, 2009, our Board of Directors increased the annual Board retainer for our
current independent directors to $110,000 (on a prorated basis) to be paid in equal installments
of:
a non-refundable payment of $55,000 payable on February 15th
of each year (for service period of February 15th to August
14th) |
||
a non-refundable payment of $55,000 payable on August 15th
of each year (for service period of August 15th to February
14th) |
During 2009, our independent directors received the following compensation:
Fees Earned or Paid in Cash | ||||||||||||||||||||
Committee Chair | Committee Meeting | |||||||||||||||||||
Annual Board | Board Meeting Fees | Retainers | Fees | |||||||||||||||||
Name | Retainer ($) | ($) | ($) | ($) | Total ($) | |||||||||||||||
Warren Pinckert |
93,333 | 11,000 | 15,000 | 14,500 | 133,833 | |||||||||||||||
John Jastrem |
93,333 | 9,000 | | 13,000 | 115,333 | |||||||||||||||
Colin OBrien |
93,333 | 11,000 | | 15,000 | 119,333 | |||||||||||||||
Brian ODonoghue |
50,625 | 5,000 | | 500 | 56,125 | |||||||||||||||
Mark Schwarz |
50,625 | 2,000 | | | 52,625 | |||||||||||||||
Andrew Vogel |
93,333 | 11,000 | 4,375 | 14,000 | 122,708 |
-26-
Table of Contents
ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT. |
Stock Ownership of our Directors, Executive Officers, and 5% Beneficial Owners
The following table shows information known to us about beneficial ownership (as defined under
the regulations of the SEC) of our common stock by:
| Each person we know to be the beneficial owner of at least five percent of our common stock; | ||
| Each current director and director nominee; | ||
| Each person named in our Summary Compensation Table; and | ||
| All current directors and executive officers as a group. |
The percentages of shares outstanding provided in the table below are based on 37,555,893
shares of common stock outstanding as of April 15, 2010. Beneficial ownership is determined in
accordance with SEC rules and regulations and generally includes voting or investment power with
respect to securities. Unless otherwise indicated, each person or entity named in the table below
has sole voting and investment power, or shares voting and investment power with his or her spouse,
with respect to all shares of stock listed as owned by that person. Shares issuable upon the
exercise of options that are exercisable within 60 days of April 15, 2010 are included in the table
below and are considered to be outstanding for the purpose of calculating the percentage of
outstanding shares of our common stock held by the individual, but not for the purpose of
calculating the percentage of outstanding shares held by any other individual. The address of our
directors and executive officers is c/o MedQuist Inc., 1000 Bishops Gate Blvd., Suite 300, Mount
Laurel, New Jersey, 08054.
-27-
Table of Contents
Number of Shares of | ||||||||
Common Stock | Percent of Shares | |||||||
Name of Beneficial Owner | Beneficially Owned | Outstanding | ||||||
CBay Inc. (1) |
26,085,086 | 69.5 | % | |||||
2661 Riva Road Building 1000, Fifth Floor Annapolis MD 21401 |
||||||||
Costa Brava Partnership III L.P. (2) |
2,367,138 | 6.3 | % | |||||
420 Boyleston Street Boston, Massachusetts 02116 |
||||||||
Directors, Named Executive Officers and Former Named Executive Officers |
||||||||
Warren E. Pinckert, II |
1,000 | | ||||||
Robert Aquilina (1) |
26,085,086 | 69.5 | % | |||||
Frank Baker (1) |
26,085,086 | 69.5 | % | |||||
Peter E. Berger (1) |
26,085,086 | 69.5 | % | |||||
Michael Seedman (1) |
26,085,086 | 69.5 | % | |||||
John F. Jastrem |
| | ||||||
Colin J. OBrien |
26,000 | | ||||||
Andrew E. Vogel |
| | ||||||
Peter Masanotti (3) |
98,583 | | ||||||
Mark R. Sullivan (4) |
2,576 | * | ||||||
Michael Clark (5) |
29,000 | * | ||||||
James Brennan |
| | ||||||
Dominick Golio |
| | ||||||
Kevin Piltz |
| | ||||||
All current directors and executive
officers as a group (14 persons)
(1) (3) (4) (5) (6) |
69.8 | % | ||||||
* | Less than one percent. | |
(1) | According to a Schedule 13D/A filed with the SEC on July 10, 2009: (i) CBay is a Delaware corporation, the principal business of which is to serve as an intermediate holding company for a portfolio of businesses that provide U.S. medical transcription, healthcare technology and healthcare financial services operations; (ii) CBaySystems is a British Virgin Islands company, the principal business of which is to serve as a holding company for a portfolio of businesses that provide medical transcription, healthcare technology and healthcare financial services operations; (iii) S.A.C. PEI CB Investment, L.P. (SAC CBI) is a Cayman Islands limited partnership, the principal business of which is to invest in securities of CBaySystems; (iv) S.A.C. PEI CB Investment GP, Limited (SAC CBI GP) is a Cayman Islands company, the principal business of which is to serve as general partner of SAC CBI; (v) S.A.C. Private Equity Investors, L.P. (SAC PEI) is a Cayman Islands limited partnership, the principal business of which is to invest in the securities of various companies; (vi) S.A.C. Private Equity GP, L.P. (SAC PEI GP) is a Cayman Islands limited partnership, the principal business of which is to serve as general partner of SAC PEI; (vii) S.A.C. Capital Management, LLC (SAC Capital Management) is a Delaware limited |
-28-
Table of Contents
liability company, the principal business of which is to serve as investment manager to certain private investment funds and to serve as general partner of SAC PEI GP; (viii) Steven A. Cohen is a resident of Connecticut, the principal business of whom is to serve as the principal of certain investment managers, including SAC Capital Management and certain other affiliated entities; and (ix) by reason of such relationships, Cohen, CBay, CBaySystems, SAC CBI, SAC CBI GP, SAC PEI, SAC PEI GP and SAC Capital Management may be deemed, pursuant to Rule 13d-3 of the Exchange Act, to be the beneficial owners of all shares of common stock held by CBay. | ||
(2) | According to a Schedule 13D/A filed with the SEC on April 17, 2009: (i) Costa Brava Partnership III L.P. (Costa Brava) is a Delaware limited partnership, the principal business of which is investing in securities; (ii) Roark, Rearden & Hamot, LLC (RRH) is a Delaware limited liability company, the principal business of which is acting as the general partner of Costa Brava; (iii) Seth W. Hamot is an individual whose principal business is serving as the President of RRH; (iv) Andrew R. Siegel is an individual whose principal business is serving as a Senior Vice President of RRH, (v) Jay Scollins is an individual whose principle business is serving as Chief Financial Officer of RRH, and (vi) by reason of such relationships, RRH, Mr. Hamot, Mr. Siegel and Mr. Scollins may be deemed, pursuant to Rule 13d-3 of the Exchange Act, to be the beneficial owners of the shares of common stock held by Costa Brava. | |
(3) | Includes options to purchase 147,875 shares of our common stock held by Mr. Masanotti that may be exercised within 60 days of April 15, 2010. | |
(4) | Includes options to purchase 2,500 shares of our common stock held by Mr. Sullivan that may be exercised within 60 days of April 15, 2010. | |
(5) | Includes options to purchase 29,000 shares of our common stock held by Mr. Clark that may be exercised within 60 days of April 15, 2010. | |
(6) | Includes our current directors (Messrs. Aquilina, Baker, Berger, Jastrem, OBrien, Pinckert, Seedman and Vogel) and our current executive officers (Messrs. Masanotti, Golio, Gold, Piltz, Sullivan, Clark, and Brennan). |
Securities Authorized for Issuance Under Equity Compensation Plans
The following table sets forth, as of December 31, 2009, information concerning equity
compensation plans under which our securities are authorized for issuance. The table does not
reflect grants, awards, exercises, terminations or expirations since that date. All share amounts
and exercise prices have been adjusted to reflect stock splits that occurred after the date on
which any particular underlying plan was adopted, to the extent applicable.
-29-
Table of Contents
(C) | ||||||||||||
(A) | Number of Securities | |||||||||||
Number of | Remaining Available | |||||||||||
Securities to be | (B) | for Future Issuance | ||||||||||
Issued Upon | Weighted Average | under Equity | ||||||||||
Exercise of | Exercise Price of | Compensation Plans | ||||||||||
Outstanding | Outstanding | (excluding securities | ||||||||||
Options, Warrants | Options, Warrants | reflected | ||||||||||
Plan Category | and Rights | and Rights | in column (A)) | |||||||||
Plans Approved by Shareholders |
1,262,168 | $ | 24.47 | 1,015,841 | (1) | |||||||
Plans Not Approved by Shareholders |
| | | |||||||||
Total |
1,262,168 | $ | 24.47 | 1,015,841 | ||||||||
(1) | This amount includes 968,601 shares of our common stock available for future issuance pursuant to stock options available for grant under our 2002 Equity Incentive Plan. |
ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS. |
Related Party Transactions
Majority Shareholder
On August 6, 2008, CBay acquired approximately 69.5% of our outstanding common stock from our
former majority shareholder, Philips. The transaction was more fully described in our Current
Report on Form 8-K filed with the SEC on August 8, 2009.
CBay
2008 TSA
On September 15, 2008, our wholly owned subsidiary, MedQuist Transcriptions, Ltd., entered
into a transcription services agreement (2008 TSA) with CBay Systems & Services, Inc. (CBay
Systems), an affiliate of our majority shareholder, CBay, pursuant to which we outsourced certain
medical transcription services to CBay Systems. The 2008 TSA was terminated by mutual written
agreement on October 26, 2009 as the agreement was no longer necessary in light of our and CBay
Systems entering into the Transcription Services Agreement described below.
For the year ended December 31, 2009, we incurred expenses of $957,774 pursuant to the 2008
TSA.
Transcription Services Agreement
On April 3, 2009, MedQuist Transcriptions, Ltd. entered into a transcription services
agreement (Transcription Services Agreement) with CBay Systems pursuant to which we outsource
certain medical transcription services to CBay Systems. Under the Transcription Services Agreement,
we pay CBay Systems a per line fee based on each transcribed line of text processed and the
specific type of service provided. CBay Systems will perform its services using our DocQment
Enterprise Platform and will be held to certain performance standards and quality guidelines set
forth in the Transcription Services
-30-
Table of Contents
Agreement. The specific services to be performed will be set forth in order forms delivered by
us to CBay Systems from time to time during the term of the Transcription Services Agreement.
The Transcription Services Agreement will expire on April 3, 2012 unless sooner terminated by
either party. Either MedQuist Transcriptions, Ltd. or CBay Systems may terminate the Transcription
Services Agreement prior to its expiration for any reason upon at least six months prior notice to
the other party. In addition, either party may terminate the Transcription Services Agreement
immediately upon written notice to the other party in the event the other party breaches any
material obligation under the Transcription Services Agreement and fails to cure such breach within
30 days or the other party files for bankruptcy.
For the year ended December 31, 2009, we incurred expenses of $5,839,926 pursuant
Transcription Services Agreement.
Subcontracting Agreement
On March 31, 2009, MedQuist Transcriptions, Ltd. entered into a transcription services
subcontracting agreement (Subcontracting Agreement) with CBay Systems, pursuant to which CBay
Systems will subcontract certain medical transcription, editing and related services to MedQuist
Transcriptions, Ltd. Under the Subcontracting Agreement, MedQuist Transcriptions, Ltd. will provide
the medical transcription, editing and related services to CBay Systems using labor located within
the United States using our DocQment Enterprise Platform. The specific services to be performed
will be set forth in order forms delivered by CBay Systems to MedQuist Transcriptions, Ltd. from
time to time during the term of the Subcontracting Agreement. MedQuist Transcriptions, Ltd. will
receive 98% of the net monthly fees collected by CBay Systems to its customers for the services
provided by MedQuist Transcriptions, Ltd.
The Subcontracting Agreement will expire on March 31, 2012 unless sooner terminated by either
party. Either MedQuist Transcriptions, Ltd. or CBay Systems may terminate the Subcontracting
Agreement prior to its expiration for any reason upon at least six months prior notice to the other
party. In addition, either party may terminate the Subcontracting Agreement immediately upon
written notice to the other party in the event the other party breaches any material obligation
under the Subcontracting Agreement and fails to cure such breach within 30 days or the other party
files for bankruptcy.
For the year ended December 31, 2009, we recorded revenue of $1,483,124 under the terms of the
Subcontracting Agreement.
Management
Services Agreement
On September 19, 2009, we entered into a services agreement (Management Services Agreement)
with CBay Inc. (CBay), pursuant to which certain senior executives and directors of CBay render to
us, upon the request of our Chief Executive Officer, certain advisory and consulting services in
relation to the our affairs and the affairs of our subsidiaries. The Management Services Agreement
will remain in effect until the earliest to occur of (i) December 31, 2009, if either party gives
notice of termination of the Services Agreement to the other party no later than December 1, 2009,
(ii) the end of any calendar quarter subsequent to December 31, 2009, if either party gives notice
of termination of the Services Agreement to the other party no later than thirty (30) days prior to
the end of such calendar quarter, (iii) such time as CBay or its affiliates (other than the us and
our subsidiaries) control, directly or indirectly, the power to vote less than thirty percent (30%)
of the issued and outstanding common equity of the MedQuist, and (iv) such earlier date as we and
CBay may mutually agree upon in writing. The Management Services Agreement provides that, in
consideration of the management services rendered by CBay to us since July
-31-
Table of Contents
1, 2009 and to be rendered by CBay to us pursuant to the Management Services Agreement, we
will pay CBay a quarterly services fee equal to $350,000, which shall be payable in arrears.
For
the year ended December 31, 2009, we incurred expenses of $700,000 in connection with
the Management Services Agreement.
To ensure the terms of the Transcription Services Agreement, the 2008 TSA, the Subcontracting
Agreement and the Management Services Agreement (collectively, the Agreements) and the transactions
arising from the Agreements are conducted at arms length, the material terms and conditions of
each of the Agreements were reviewed and approved by the Audit Committee of the our board of
directors pursuant to our Related Party Transaction Policy. Our Audit Committee is comprised solely
of independent directors, none of whom have an interest in either of the Agreements or the
transactions arising from the Agreements.
Sales & Services Agreement
On March 9, 2010, we entered into the Sales & Services Agreement with CBay Systems, pursuant
to which we outsource certain medical transcription services to CBay Systems. Under the Sales &
Services Agreement, CBay Systems has discontinued its new customer marketing efforts for
transcription services to hospitals in North America and has become the exclusive supplier to us of
Asian based transcription production services, which are either performed directly by CBay Systems
or through a network of third party suppliers managed by CBay Systems. Under the Sales & Services
Agreement, we pay CBay Systems a per line fee based on each transcribed line of text processed and
the specific type of service provided. The Sales & Services Agreement will expire on March 10,
2015, and thereafter shall automatically renew for two additional five year terms, unless either
party provides the other with written notice of its election to terminate the agreement at the end
of the initial term or at the end of a renewal term, provided such notice is provided to the other
party, not earlier than 12 months nor less than six months prior to the end of the initial term or
the applicable renewal term. Either we or CBay may terminate the Sales & Services Agreement if the
other party materially breaches any term of the agreement, or in the event CBay Systems and its
affiliates (other than us or our subsidiaries) cease to control, directly or indirectly, the power
to vote at least thirty percent (30%) of the issued and outstanding common equity of us. The Sales
& Services Agreement will be filed as an exhibit to our Quarterly Report on Form 10-Q for the
quarter ending March 31, 2010, with portions omitted and filed separately with the SEC pursuant to
a request for confidential treatment. We did not incur any expenses under the Sales & Service
Agreement during the fiscal year ended December 31, 2009.
Services Provided by CBay
For
the year ended December 31, 2009, we incurred services expenses
of $699,000 in connection
with management services provided to us by CBay (2009 CBay Management Services), prior to our entry
into the Management Services Agreement with CBay described above.
Payment of the fees charged with respect to the 2009 CBay Management Services was reviewed and
approved by the Audit Committee of our board of directors pursuant to our Related Party Transaction
Policy.
Indemnification Agreements
On August 23, 2007, we entered into indemnification agreements with Messrs. Brennan, Sullivan
and Clark (Officer Indemnification Agreements). Each indemnification agreement is substantially
similar and provides, among other things, that to the extent permitted by New Jersey law, we will
indemnify the executive officer against all expenses (including attorneys fees), judgments, fines
and amounts paid in
-32-
Table of Contents
settlement actually and reasonably incurred by him or her in conjunction with any suit in
which he or she is a party or otherwise involved as a result of his or her service as an executive
officer. Each of these indemnification agreements was amended on August 19, 2008 to require us to
obtain and maintain insurance policies providing our executive officers with coverage for losses in
connection with their acts or omissions or to ensure our performance of our indemnification
obligations under the indemnification agreements.
On February 21, 2008, we entered into an indemnification agreement with Mr. Pinckert. The
indemnification agreement is substantially similar to the Officer Indemnification Agreements and
provides, among other things, that to the extent permitted by New Jersey law, we will indemnify
each of Mr. Pinckert against all expenses (including attorneys fees), judgments, fines and amounts
paid in settlement actually and reasonably incurred by him in connection with any suit in which he
is a party or otherwise involved as a result of his service as a member of our board of directors.
On August 19, 2008, we entered into indemnification agreements with Messrs. Aquilina, Baker,
Berger and Seedman. Each indemnification agreement is substantially similar to the Officer
Indemnification Agreements and provides, among other things, that to the extent permitted by New
Jersey law, we will indemnify each of Messrs. Aquilina, Baker, Berger and Seedman against all
expenses (including attorneys fees), judgments, fines and amounts paid in settlement actually and
reasonably incurred by him in connection with any suit in which he is a party or otherwise involved
as a result of his service as a member of our board of directors.
On November 21, 2008, we entered into indemnification agreements with Messrs. Jastrem,
Masanotti, OBrien and Vogel. Each indemnification agreement is substantially similar to the
Officer Indemnification Agreements and provides, among other things, that to the extent permitted
by New Jersey law, we will indemnify each of Messrs. Jastrem, Masanotti, OBrien and Vogel against
all expenses (including attorneys fees), judgments, fines and amounts paid in settlement actually
and reasonably incurred by him in connection with any suit in which he is a party or otherwise
involved as a result of his service as a member of our board of directors, or as our President and
Chief Executive Officer, as applicable.
Our Policies Regarding Related Party Transactions
In August 2007, our board of directors adopted a written policy which charges the Audit
Committee (or the disinterested members of our board of directors) with the responsibility of
approving or ratifying all related party transactions other.
On July 28, 2009, our board of directors amended the related transaction policy with respect
to compensation to provide that: (A) if the related party transaction involves compensation of a
related party, other than CBay, Inc. or its affiliates, such transaction must be approved by the
Compensation Committee and (B) if the related party transaction involves compensation of CBay, Inc.
or its affiliates, such transaction must be approved by the Audit Committee. In addition, the
amendment to the policy removed the references to Koninklijke Philips Electronics N.V. (Philips),
our former controlling shareholder and the Supervisory Committee, a committee of our board of
directors which had certain responsibilities with regard to our relationship with Philips when it
was our controlling shareholder. The Supervisory Committee was disbanded in 2008.
Accordingly, as of July 28, 2009, a related party transaction is a transaction between us
and any related party other than (i) transactions available to all of our employees generally, and
(ii) transactions involving less than $5,000 when aggregated with all similar transactions.
-33-
Table of Contents
From August 2007 to July 28, 2009, if the related party transaction involved compensation,
such transaction had to also be approved by the Compensation Committee. From August 2007 to July
28, 2009, according to the policy, a related party transaction was a transaction between us and
any related party other than (i) transactions available to all of our employees generally, (ii)
transactions involving less than $5,000 when aggregated with all similar transactions and (iii)
transactions with Philips that were subject to the approval of the Supervisory Committee as
described above.
A related party, according to the policy, is any one of the following:
| any of our executive officers or directors; | ||
| any shareholder owning more than 5% of our stock; | ||
| any person who is an immediate family member of our executive officers or directors; or | ||
| any entity in which any of the above has a substantial ownership interest or control. |
Since the adoption of the policy set forth above there have been no transactions that would be
subject to the policy that have not been approved pursuant to the policy, with the exception of the
Management Services Agreement and the payment of fees related to the 2009 CBay Management Services,
each of which was approved solely by the Audit Committee.
As described above, prior to the amendment to the policy on July 28, 2009, transactions
involving compensation had to be approved by the Audit Committee and the Compensation Committee. A
majority of the members of the Compensation Committee were and are affiliated with CBay, Inc. and
such members provided management services to us in 2009 prior to the Management Services Agreement,
and will continue to provide services to us under the Management Services Agreement. Due to the
potential conflict of interest of a majority of the members of the Compensation Committee, our
board of directors approved an exception to our policy allowing for the 2009 CBay Management
Services and the Management Services Agreement to only be approved by the Audit Committee.
Independence of Directors
For information regarding the independence of our directors, please see the discussion under
Item 10, below the heading Independence of Directors, which discussion is incorporated herein by
reference.
-34-
Table of Contents
ITEM 14. | PRINCIPAL ACCOUNTANT FEES AND SERVICES. |
The Audit Committee of our board of directors is responsible for the appointment,
compensation, oversight and replacement, if necessary, of our independent registered public
accounting firm. In accordance with the charter of the Audit Committee, the Audit Committee must
approve, in advance of the service, all audit, internal control-related and permissible non-audit
services provided by our independent registered public accounting firm, subject to a de minimis
exception for non-audit services. In its review of non-audit service fees, the Audit Committee
considers, among other things, the possible effect of the performance of such services on the
independence of our independent registered public accounting firm. Our independent registered
public accounting firm may not be retained to perform any of the non-audit services specified in
Section 10A(g) of the Exchange Act.
All services provided by KPMG LLP, our independent registered accounting firm, for the years
ended December 31, 2009 and 2008 were preapproved by the Audit Committee.
Fees Paid to the Principal Accountant 2009 and 2008
The following table sets forth the aggregate fees billed to us for the years ended December
31, 2009 and 2008 by KPMG LLP (in thousands):
Fees | 2009 | 2008 | ||||||
Audit Fees (1) |
$ | 1,279 | $ | 2,494 | ||||
Audit-Related Fees(2) |
185 | 55 | ||||||
Tax Fees (3) |
96 | 272 | ||||||
All Other Fees |
| | ||||||
Total Fees |
$ | 1,560 | $ | 2,821 |
(1) | Audit Fees represents aggregate fees paid or accrued for the audit of our internal control over financial reporting as required by Section 404, the audit of managements assessment of our internal control over financial reporting, the audit of our annual financial statements and review of our interim financial statements, and fees for services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings. | |
(2) | Audit-Related Fees represents fees for professional services rendered in connection with KPMGs assistance to us for the due diligence associated with CBays August 2008 purchase of Philips majority interest in us and with the Companys 2010 acquisition of Spheris | |
(3) | Tax Fees represents fees for all professional services rendered by our independent registered public accounting firms tax professionals, except those related to the audit of our financial statements, including tax compliance, tax advice and tax planning. |
-35-
Table of Contents
PART IV
ITEM 15. | EXHIBITS AND FINANCIAL STATEMENT SCHEDULES |
(a) Documents filed as part of this report:
(3) Exhibits. See (b) below.
(b) Exhibits:
3.1(1)
|
Certificate of Incorporation of MedQuist Inc. (as amended) | |
3.2(6)
|
Second Amended and Restated By-Laws, as amended, of MedQuist Inc. | |
4.1(1)
|
Specimen Stock Certificate | |
10.1*(1)
|
1992 Stock Option Plan of MedQuist Inc., as amended | |
10.2*(1)
|
Nonstatutory Stock Option Plan for Non-Employee Directors of MedQuist Inc. | |
10.3*(1)
|
MedQuist Inc. 2002 Stock Option Plan | |
10.4*(1)
|
Form of Award Agreement under the MedQuist Inc. 2002 Stock Option Plan | |
10.5*(1)
|
1996 Employee Stock Purchase Plan | |
10.6*(1)
|
MedQuist Inc. Executive Deferred Compensation Plan | |
10.7*(1)
|
Letter Agreement, dated as of April 21, 2005, between MedQuist Inc. and Michael Clark | |
10.8*(1)
|
Letter Agreement, dated as of April 21, 2005, between MedQuist Inc. and Mark Sullivan | |
10.10*(1)
|
Letter Agreement, dated as of November 10, 2006, by and between MedQuist Inc. and James Brennan | |
10.11(1)
|
Licensing Agreement, dated as of May 22, 2000, between MedQuist Inc. and Philips Speech Processing GmbH | |
10.11.1(1)
|
Amendment No. 1 to Licensing Agreement, dated as of January 1, 2002, between MedQuist Inc. and Philips Speech Processing GmbH | |
10.11.2#(1)
|
Amendment No. 2 to Licensing Agreement, dated as of December 10, 2002, between MedQuist Inc. and Philips Speech Processing GmbH | |
10.11.3#(1)
|
Amendment No. 3 to Licensing Agreement, dated as of August 10, 2003, between MedQuist Inc. and Philips Speech Processing GmbH | |
10.11.4#(1)
|
Amendment No. 4 to Licensing Agreement, dated as of September 1, 2004, between MedQuist Inc. and Philips Speech Processing GmbH | |
10.11.5#(1)
|
Amendment No. 5 to Licensing Agreement, dated as of December 30, 2005, between MedQuist Transcriptions, Ltd. and Philips Speech Recognition Systems GmbH f/k/a Philips Speech Processing GmbH | |
10.11.6#(1)
|
Amendment No. 6 to Licensing Agreement, dated as of February 13, 2007, between MedQuist Inc. and Philips Speech Recognition Systems GmbH f/k/a Philips Speech Processing GmbH |
-36-
Table of Contents
10.11.7(16)
|
Amendment No. 7 to Licensing Agreement, dated as of November 10, 2009, between MedQuist Inc. and Nuance Communications, Inc. as the successor-in-interest to Philips Speech Recognition Systems GmbH | |
10.12(16)##
|
Third Amended and Restated OEM Supply Agreement dated November 10, 2009, between MedQuist Inc. and Nuance Communications, Inc. as the successor-in-interest to Philips Speech Recognition Systems GmbH | |
10.13(1)
|
Mt. Laurel, New Jersey Office Lease Agreement dated as of June 17, 2003 | |
10.13.1(1)
|
First Amendment to Mt. Laurel, New Jersey Office Lease Agreement dated as of August 26, 2003 | |
10.13.2(1)
|
Second Amendment to Mt. Laurel, New Jersey Office Lease Agreement dated as of November 30, 2003 | |
10.13.3(1)
|
Third Amendment to Mt. Laurel, New Jersey Office Lease Agreement dated as of November 30, 2003 | |
10.13.4(1)
|
Confirmation of Lease Term regarding Mt. Laurel, New Jersey Office Lease dated as of August 10, 2006 | |
10.15*(2)
|
Form of Management Indemnification Agreement by and between MedQuist Inc. and Certain Officers | |
10.15.1*(7)
|
First Amendment to the Form of Management Indemnification Agreement by and between MedQuist Inc. and Certain Officers | |
10.16*(4)
|
Indemnification Agreement, dated as of February 21, 2008 between MedQuist Inc. and Warren Pinckert | |
10.17*(8)
|
Employment Agreement by and between Peter Masanotti and MedQuist Inc., dated September 3, 2008 | |
10.18#(9)
|
Transcription Services Agreement by and between MedQuist Transcriptions, Ltd. and CBay Systems & Services, Inc. dated April 3, 2009 | |
10.19*(10)
|
Indemnification Agreement dated November 21, 2008 between MedQuist Inc. and Peter Masanotti | |
10.20*(11)
|
Amended and Restated Stock Option Agreement by and between Peter Masanotti and MedQuist Inc., dated March 2, 2009 | |
10.21*(9)
|
Employment Agreement by and between Alan Gold and MedQuist Inc. dated February 26, 2009 | |
10.22*(12)
|
Employment Agreement by and between Dominick Golio and MedQuist Inc. dated April 9, 2009 | |
10.23*(9)
|
Employment Agreement by and between Kevin Piltz and MedQuist Inc. dated May 18, 2009 | |
10.24(9)
|
Settlement and License Agreement by and between Anthurium Solutions, Inc. and MedQuist Inc. dated June 19, 2009 | |
10.25*(13)
|
MedQuist Inc. Long-Term Incentive Plan adopted on August 27, 2009 | |
10.26(13)
|
Credit Agreement by and among MedQuist Inc. and its subsidiaries, and Wells Fargo Foothill, LLC as the arranger and administrative agent and lender dated August 31, 2009 | |
10.27(14)
|
Services Agreement by and between MedQuist Inc. and CBay Inc. dated September 19, 2009 |
-37-
Table of Contents
10.28(16)##
|
Licensing Agreement by and between Nuance Communications, Inc. and MedQuist Inc. dated November 10, 2009 | |
10.29(15)
|
Transcription Services Subcontracting Agreement by and between MedQuist Inc. and CBay Systems & Services, Inc. dated March 31, 2009 | |
10.30(17)
|
Stock and Asset Purchase Agreement, dated April 15, 2010, between Spheris Holding II, Inc., Spheris Inc., Spheris Operations LLC, Vianeta Communications, Spheris Leasing LLC, Spheris Canada Inc., CBay Inc. and MedQuist Inc. | |
10.31(18)
|
Credit Agreement dated as April 22, 2010 among MedQuist Transcriptions, Ltd. as Borrower, MedQuist Inc. as Holdings, the Lenders and L/C Issuers party thereto, and General Electric Capital Corporation as Administrative Agent and Collateral Agent, CapitalSource Bank as Syndication Agent, and Fifth Third Bank as Documentation Agent. | |
21(1)
|
Subsidiaries of MedQuist Inc. | |
23 (16)
|
Consent of KPMG LLP | |
24 (16)
|
Power of Attorney | |
31.1
|
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2
|
Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
* | Management contract or compensatory plan or arrangement. | |
# | Portions of this Exhibit were omitted and filed separately with the Secretary of the SEC pursuant to an order for confidential treatment from SEC. | |
## | Portions of this Exhibit were omitted and filed separately with the Secretary of the SEC pursuant to a request for confidential treatment that has been filed with the SEC. | |
(1) | Incorporated by reference to our Annual Report on Form 10-K for the year ended December 31, 2005 filed on July 5, 2007 | |
(2) | Incorporated by reference to our Current Report on Form 8-K filed on August 28, 2007 | |
(3) | Incorporated by reference to our Current Report on Form 8-K filed on September 25, 2007 | |
(4) | Incorporated by reference to our Current Report on Form 8-K filed on February 22, 2008 | |
(5) | Incorporated by reference to our Annual Report on Form 10-K for the year ended December 31, 2007 filed on March 17, 2008 |
-38-
Table of Contents
(6) | Incorporated by reference to our Current Report on Form 8-K filed on July 15, 2008 | |
(7) | Incorporated by reference to our Current Report on Form 8-K filed on August 25, 2008 | |
(8) | Incorporated by reference to our Current Report on Form 8-K filed on September 9, 2008 | |
(9) | Incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 filed on July 30, 2009 | |
(10) | Incorporated by reference to our Current Report on Form 8-K filed on November 28, 2008 | |
(11) | Incorporated by reference to our Current Report on Form 8-K filed on March 6, 2009 | |
(12) | Incorporated by reference to our Current Report on Form 8-K filed with the SEC on April 15, 2009 | |
(13) | Incorporated by reference to our Quarterly Report on Form 10-Q filed on November 9, 2009 | |
(14) | Incorporated by reference to our Current Report on Form 8-K filed with the SEC on September 24, 2009 | |
(15) | Incorporated by reference to our Current Report on Form 8-K filed on April 6, 2009 | |
(16) | Incorporated by reference to our Annual Report on Form 10-K for the year ended December 31, 2009 filed on March 12, 2010 | |
(17) | Incorporated by reference to our Current Report on Form 8-K filed with the SEC on April 21, 2010 | |
(18) | Incorporated by reference to our Current Report on Form 8-K filed with the SEC on April 28, 2010 |
-39-
Table of Contents
SIGNATURES |
Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MedQuist Inc. |
||||
By: | /s/ Peter Masanotti | |||
Peter Masanotti | ||||
President and Chief Executive Officer | ||||
Date: April 30, 2010 | ||||
Pursuant
to the requirements of the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated.
Signature | Capacity | Date | ||
/s/ Peter Masanotti
|
President and Chief Executive Officer (Principal Executive Officer) |
April 30, 2010 | ||
/s/ Dominick Golio
|
Chief Financial Officer (Principal Financial Officer) |
April 30, 2010 | ||
/s/ James Brennan
|
Principal Accounting Officer, Controller and Vice President |
April 30, 2010 | ||
*
|
Non-Executive Chairman of the Board of Directors |
April 30, 2010 | ||
*
|
Director | April 30, 2010 | ||
*
|
Director | April 30, 2010 | ||
*
|
Director | April 30, 2010 | ||
*
|
Director | April 30, 2010 | ||
*
|
Director | April 30, 2010 | ||
*
|
Director | April 30, 2010 |
-40-
Table of Contents
Signature | Capacity | Date | ||
*
|
Director | April 30, 2010 |
*By: | /s/ Peter Masanotti | |||
Attorney-In-Fact | ||||
-41-
Table of Contents
EXHIBIT INDEX
Exhibit | Description | |
21
|
Subsidiaries of MedQuist Inc. | |
31.1
|
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2
|
Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
-42-